Cited by 229

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Highly Coordinated Proteome Dynamics during Reprogramming of Somatic Cells to Pluripotency

Hansson, Jenny, Rafiee, Mahmoud Reza, Reiland, Sonja, Polo, Jose M., Gehring, Julian, Okawa, Satoshi, Huber, Wolfgang, Hochedlinger, Konrad, Krijgsveld, Jeroen·2012·Cell Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2012.10.014

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cellular reprogramming to pluripotency by forced expression of the Yamanaka factors occurs through global remodeling of epigenetic marks.

    “Cellular reprogramming to pluripotency by forced expression of the Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc [OSKM]) occurs through the global remodeling of epigenetic marks”

    From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Hansson et al., 2012

    The Introduction (page unavailable) states that forced expression of Oct4, Klf4, Sox2 and c-Myc reprograms somatic cells and that reprogramming is accompanied by remodeling of chromatin programs. The Results (page unavailable) also describe DNA methyltransferases involved in altering the epigenetic landscape. These passages support epigenetic remodeling during reprogramming, but do not establish that global remodeling of epigenetic marks is the mechanism through which it occurs. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Electron transport chain proteins are downregulated in the first 3 days of reprogramming before a gradual metabolic switch to glycolysis, a characteristic typically seen in rapidly proliferating cells.

    “Similar to gene expression changes, clustering analysis of proteins with temporal expression dynamics similar to gene expression changes reveals that electron transport chain proteins are downregulated in the first 3 days of reprogramming before a gradual metabolic switch to glycolysis, a characteristic that is typically seen in rapidly proliferating cells 84,97 .”

    From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [84]

    The Results section, “The metabolic switch to glycolysis is preceded by a stoichiometric change in the electron transport system,” supports an early decrease in some electron transport proteins followed by a gradual shift toward glycolysis, which it describes as characteristic of fast-proliferating cells. But it specifies that only complexes I and IV were downregulated by day 3; complexes II, III and V increased. The claim overgeneralizes the downregulation to electron transport chain proteins as a whole. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Such changes were highly correlated with altered cell division, DNA replication, chromatin modification and DNA damage response protein levels.

    “Such changes were highly correlated with altered cell division, DNA replication, chromatin modification and the DNA damage response protein levels 84 .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 74

  1. Ahmed, 2006, Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium, Am. J. Physiol. Cell Physiol., 290, C1532, 10.1152/ajpcell.00478.2005 · DOI
  2. Ashburner, 2000, Gene ontology: tool for the unification of biology, Nat. Genet., 25, 25, 10.1038/75556 · DOI · Paper page
  3. Begum, 2012, DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo, Cancer Lett., 318, 26, 10.1016/j.canlet.2011.11.032 · DOI
  4. Boekema, 2007, Supramolecular structure of the mitochondrial oxidative phosphorylation system, J. Biol. Chem., 282, 1, 10.1074/jbc.R600031200 · DOI
  5. Boersema, 2009, Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics, Nat. Protoc., 4, 484, 10.1038/nprot.2009.21 · DOI
  6. Brambrink, 2008, Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells, Cell Stem Cell, 2, 151, 10.1016/j.stem.2008.01.004 · DOI
  7. Chang, 2012, 14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β, PLoS ONE, 7, e40193, 10.1371/journal.pone.0040193 · DOI
  8. Chen, 2011, Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells, Stem Cell Rev., 7, 722, 10.1007/s12015-011-9233-y · DOI
  9. Cox, 2008, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification, Nat. Biotechnol., 26, 1367, 10.1038/nbt.1511 · DOI · Paper page
  10. D’Angelo, 2012, A change in nuclear pore complex composition regulates cell differentiation, Dev. Cell, 22, 446, 10.1016/j.devcel.2011.11.021 · DOI
  11. DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002 · DOI · Paper page
  12. Du, 2010, O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation, Dev. Biol., 346, 25, 10.1016/j.ydbio.2010.07.008 · DOI
  13. Eriksson, 2004, Dynamic properties of nuclear pore complex proteins in gp210 deficient cells, FEBS Lett., 572, 261, 10.1016/j.febslet.2004.07.044 · DOI
  14. Feng, 2009, Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb, Nat. Cell Biol., 11, 197, 10.1038/ncb1827 · DOI
  15. Feng, 2009, Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells, Cell Stem Cell, 4, 301, 10.1016/j.stem.2009.03.005 · DOI
  16. Folmes, 2011, Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming, Cell Metab., 14, 264, 10.1016/j.cmet.2011.06.011 · DOI
  17. Ghule, 2011, Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells, J. Cell. Physiol., 226, 1149, 10.1002/jcp.22440 · DOI
  18. Gowher, 2005, Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L, J. Biol. Chem., 280, 13341, 10.1074/jbc.M413412200 · DOI
  19. Gundry, 2012, A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells, Mol. Cell. Proteomics, 11, 303, 10.1074/mcp.M112.018135 · DOI
  20. Guo, 2004, Integrin signalling during tumour progression, Nat. Rev. Mol. Cell Biol., 5, 816, 10.1038/nrm1490 · DOI
  21. Hanna, 2009, Direct cell reprogramming is a stochastic process amenable to acceleration, Nature, 462, 595, 10.1038/nature08592 · DOI · Paper page
  22. Hayashi, 2007, Integrins regulate mouse embryonic stem cell self-renewal, Stem Cells, 25, 3005, 10.1634/stemcells.2007-0103 · DOI
  23. Huang, 2012, Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling, J. Proteome Res., 11, 2091, 10.1021/pr300155r · DOI
  24. Huangfu, 2008, Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds, Nat. Biotechnol., 26, 795, 10.1038/nbt1418 · DOI
  25. Imamichi, 2007, Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition, Cells Tissues Organs (Print), 185, 180, 10.1159/000101319 · DOI
  26. Jiang, 2008, A core Klf circuitry regulates self-renewal of embryonic stem cells, Nat. Cell Biol., 10, 353, 10.1038/ncb1698 · DOI
  27. Krizhanovsky, 2009, Stem cells: The promises and perils of p53, Nature, 460, 1085, 10.1038/4601085a · DOI · Paper page
  28. Kumar, 2007, Mfuzz: a software package for soft clustering of microarray data, Bioinformation, 2, 5, 10.6026/97320630002005 · DOI
  29. Kuroda, 1998, Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion, Science, 281, 832, 10.1126/science.281.5378.832 · DOI
  30. Li, 2010, A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Cell Stem Cell, 7, 51, 10.1016/j.stem.2010.04.014 · DOI · Paper page
  31. Lister, 2011, Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, Nature, 471, 68, 10.1038/nature09798 · DOI
  32. Loh, 2011, Genomic approaches to deconstruct pluripotency, Annu. Rev. Genomics Hum. Genet., 12, 165, 10.1146/annurev-genom-082410-101506 · DOI
  33. Maherali, 2009, Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc, Curr. Biol., 19, 1718, 10.1016/j.cub.2009.08.025 · DOI · Paper page
  34. Maherali, 2007, Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution, Cell Stem Cell, 1, 55, 10.1016/j.stem.2007.05.014 · DOI · Paper page
  35. Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 · DOI
  36. Mi, 2007, PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways, Nucleic Acids Res., 35, D247, 10.1093/nar/gkl869 · DOI
  37. Mikkelsen, 2008, Dissecting direct reprogramming through integrative genomic analysis, Nature, 454, 49, 10.1038/nature07056 · DOI
  38. Morel, 2008, Generation of breast cancer stem cells through epithelial-mesenchymal transition, PLoS ONE, 3, e2888, 10.1371/journal.pone.0002888 · DOI
  39. Munoz, 2011, The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells, Mol. Syst. Biol., 7, 550, 10.1038/msb.2011.84 · DOI
  40. Nikolsky, 2005, A novel method for generation of signature networks as biomarkers from complex high throughput data, Toxicol. Lett., 158, 20, 10.1016/j.toxlet.2005.02.004 · DOI
  41. Nistala, 2010, Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation, J. Cell Biol., 190, 1107, 10.1083/jcb.201003089 · DOI
  42. Nitzsche, 2011, RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity, PLoS ONE, 6, e19470, 10.1371/journal.pone.0019470 · DOI
  43. Olsson, 2004, Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans, Exp. Cell Res., 292, 359, 10.1016/j.yexcr.2003.09.014 · DOI
  44. Onder, 2012, Chromatin-modifying enzymes as modulators of reprogramming, Nature, 483, 598, 10.1038/nature10953 · DOI
  45. Pardo, 2010, An expanded Oct4 interaction network: implications for stem cell biology, development, and disease, Cell Stem Cell, 6, 382, 10.1016/j.stem.2010.03.004 · DOI · Paper page
  46. Park, 2008, Reprogramming of human somatic cells to pluripotency with defined factors, Nature, 451, 141, 10.1038/nature06534 · DOI · Paper page
  47. Phanstiel, 2011, Proteomic and phosphoproteomic comparison of human ES and iPS cells, Nat. Methods, 8, 821, 10.1038/nmeth.1699 · DOI
  48. Plath, 2011, Progress in understanding reprogramming to the induced pluripotent state, Nat. Rev. Genet., 12, 253, 10.1038/nrg2955 · DOI
  49. Rigbolt, 2011, GProX, a user-friendly platform for bioinformatics analysis and visualization of quantitative proteomics data, Mol. Cell. Proteomics, 10, 10.1074/mcp.O110.007450 · DOI
  50. Robbs, 2008, Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors, Mol. Cell. Biol., 28, 7168, 10.1128/MCB.00256-08 · DOI
  51. Ruiz, 2011, A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity, Curr. Biol., 21, 45, 10.1016/j.cub.2010.11.049 · DOI
  52. Samavarchi-Tehrani, 2010, Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming, Cell Stem Cell, 7, 64, 10.1016/j.stem.2010.04.015 · DOI · Paper page
  53. Smith, 2010, Dynamic single-cell imaging of direct reprogramming reveals an early specifying event, Nat. Biotechnol., 28, 521, 10.1038/nbt.1632 · DOI
  54. Stadtfeld, 2010, A reprogrammable mouse strain from gene-targeted embryonic stem cells, Nat. Methods, 7, 53, 10.1038/nmeth.1409 · DOI
  55. Stavru, 2006, Nuclear pore complex assembly and maintenance in POM121- and gp210-deficient cells, J. Cell Biol., 173, 477, 10.1083/jcb.200601002 · DOI
  56. Terme, 2011, Histone H1 variants are differentially expressed and incorporated into chromatin during differentiation and reprogramming to pluripotency, J. Biol. Chem., 286, 35347, 10.1074/jbc.M111.281923 · DOI
  57. van Raam, 2008, Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation, PLoS One, 3, e2013, 10.1371/journal.pone.0002013 · DOI
  58. Wang, 2008, Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation, Nat. Genet., 40, 1478, 10.1038/ng.250 · DOI
  59. White, 2009, IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis, FEBS Lett., 583, 1817, 10.1016/j.febslet.2009.05.007 · DOI
  60. Wong, 2008, High-efficiency stem cell fusion-mediated assay reveals Sall4 as an enhancer of reprogramming, PLoS One, 3, e1955, 10.1371/journal.pone.0001955 · DOI
  61. Wu, 2011, Harnessing the potential of induced pluripotent stem cells for regenerative medicine, Nat. Cell Biol., 13, 497, 10.1038/ncb0511-497 · DOI
  62. Yang, 2006, P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin, Cell, 127, 139, 10.1016/j.cell.2006.08.036 · DOI
  63. Zhu, 2010, Reprogramming of human primary somatic cells by OCT4 and chemical compounds, Cell Stem Cell, 7, 651, 10.1016/j.stem.2010.11.015 · DOI · Paper page
  64. Ziller, 2011, Genomic distribution and inter-sample variation of non-CpG methylation across human cell types, PLoS Genet., 7, e1002389, 10.1371/journal.pgen.1002389 · DOI
  65. Boersema, P.J., Raijmakers, R., Lemeer, S., Mohammed, S., and Heck, A.J. (2009). Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 4, 484–494. · DOI
  66. Cox, J., and Mann, M. (2008). MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372. · DOI · Paper page
  67. Huber, W., von Heydebreck, A., Sueltmann, H., Poustka, A., and Vingron, M. (2003). Parameter estimation for the calibration and variance stabilization of microarray data. Stat. Appl. Genet. Mol. Biol. 2, Article3. · DOI
  68. Kumar, L., and Futschik, M.E. (2007). Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2, 5–7. · DOI
  69. Mi, H., Guo, N., Kejariwal, A., and Thomas, P.D. (2007). PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res. 35(Database issue), D247–D252. · DOI
  70. Nikolsky, Y., Ekins, S., Nikolskaya, T., and Bugrim, A. (2005). A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 158, 20–29. · DOI
  71. Rappsilber, J., Mann, M., and Ishihama, Y. (2007). Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896–1906. · DOI · Paper page
  72. Rigbolt, K.T., Vanselow, J.T., and Blagoev, B. (2011). GProX, a user-friendly platform for bioinformatics analysis and visualization of quantitative proteomics data. Mol. Cell. Proteomics 10, O110.007450. · DOI
  73. Ruepp, A., Waegele, B., Lechner, M., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., and Mewes, H.W. (2010). CORUM: the comprehensive resource of mammalian protein complexes—2009. Nucleic Acids Res. 38(Database issue), D497–D501. · DOI
  74. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., and Selbach, M. (2011). Global quantification of mammalian gene expression control. Nature 473, 337–342. · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Hansson, J., Rafiee, M. R., Reiland, S., Polo, J. M., Gehring, J., Okawa, S., Huber, W., Hochedlinger, K., & Krijgsveld, J.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2012-12
Volume
2
Issue
6
Pages
1579-1592
ISSN
2211-1247
Cited by
229
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review